Shang Hai Zheng Quan Bao·2026-03-16 18:41Core Viewpoint - The shareholders of Beijing Zhaoyan New Drug Research Center Co., Ltd. plan to reduce their holdings of A-shares, which may impact the company's stock performance and investor sentiment [1][2]. Shareholder Holding Situation - Shareholder Gu Xiaolei holds 20,420,504 shares (2.7251% ownership), while Gu Meifang holds 10,322,035 shares (1.3775% ownership) [1]. Reduction Plan Details - Gu Xiaolei and Gu Meifang intend to reduce their holdings by a total of 30,742,539 shares, representing 4.1026% of the company's total share capital, through centralized bidding on the Shanghai Stock Exchange within three months from the announcement date [2][4]. Shareholder Commitment - The shareholders have committed to announce their reduction plans three trading days prior to any share reduction, and the reduction will be conducted in compliance with legal regulations [5]. Control and Governance Impact - The reduction plan will not lead to a change in the company's control or governance structure, as the shareholders are not the controlling shareholders or actual controllers of the company [6].